文献速递细菌感染、耐药与抗菌药物

复发性革兰阴性菌血流感染的临床与分子分析

Clinical and Molecular Analyses of Recurrent Gram-Negative Bloodstream Infections.
PubMed 文献 · Clin Infect Dis · 2023-01-01

研究纳入1423例革兰阴性菌血流感染患者,其中60例(4%)复发。非白人种族、外科入院和留置心脏装置与复发风险升高相关。48例配对分离株经全基因组测序分析,63%为复发、38%为再感染,脉冲场凝胶电泳与全基因组测序一致率达98%。心脏装置与复发相关。

要点

  • 1423例革兰阴性菌血流感染中60例(4%)复发。
  • 非白人种族、外科入院、留置心脏装置与复发风险升高相关。
  • 全基因组测序显示63%复发为再燃、38%为再感染,脉冲场凝胶电泳一致率98%。

核心结论

  • 本研究中复发性革兰阴性菌血流感染最常见于再燃。
  • 与全基因组测序相比,脉冲场凝胶电泳可准确区分再燃与再感染。
  • 心脏装置是再燃的危险因素。

研究设计与样本

  • 研究采用革兰阴性菌血流感染患者队列,以识别复发性革兰阴性菌血流感染的临床特征、微生物学及危险因素。
  • 采用脉冲场凝胶电泳和全基因组测序进行细菌基因分型,以判断复发事件为再燃还是再感染。
  • 采用多因素logistic回归识别复发危险因素。

主要发现

  • 1423例革兰阴性菌血流感染患者中,60例(4%)出现复发性革兰阴性菌血流感染。
  • 非白人种族与复发风险升高相关(OR 2.35;95%CI 1.38-4.01;P=0.002)。
  • 外科入院与复发风险升高相关(OR 2.18;95%CI 1.26-3.75;P=0.005)。
  • 留置心脏装置与复发风险升高相关(OR 2.73;95%CI 1.21-5.58;P=0.009)。
  • 48例配对血流分离株经全基因组测序分析,63%(30/48)为再燃,38%(18/48)为再感染;脉冲场凝胶电泳正确区分再燃与再感染98%(47/48)。

关键数值与推荐

  • 再燃与再感染的中位时间相似(再燃113天,IQR 35-222;再感染174天,IQR 69-599;P=0.13)。
  • 心脏装置与再燃相关(再燃组7/27,26%;非再燃组65/988,7%;P=0.002)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The causes and clinical characteristics of recurrent gram-negative bacterial bloodstream infections (GNB-BSI) are poorly understood. METHODS: We used a cohort of patients with GNB-BSI to identify clinical characteristics, microbiology, and risk factors associated with recurrent GNB-BSI. Bacterial genotyping (pulsed-field gel electrophoresis [PFGE] and whole-genome sequencing [WGS]) was used to determine whether episodes were due to relapse or reinfection. Multivariable logistic regression was used to identify risk factors for recurrence. RESULTS: Of the 1423 patients with GNB-BSI in this study, 60 (4%) had recurrent GNB-BSI. Non-White race (odds ratio [OR], 2.35; 95% confidence interval [CI], 1.38-4.01; P = .002), admission to a surgical service (OR, 2.18; 95% CI, 1.26-3.75; P = .005), and indwelling cardiac device (OR, 2.73; 95% CI, 1.21-5.58; P = .009) were associated with increased risk for recurrent GNB-BSI. Among the 48 patients with recurrent GNB-BSI whose paired bloodstream isolates underwent genotyping, 63% were due to relapse (30 of 48) and 38% were due to reinfection (18 of 48) based on WGS. Compared with WGS, PFGE correctly differentiated relapse and reinfection in 98% (47 of 48) of cases. Median time to relapse and reinfection was similar (113 days; interquartile range [IQR], 35-222 vs 174 days; IQR, 69-599; P = .13). Presence of a cardiac device was associated with relapse (relapse: 7 of 27, 26%; nonrelapse: 65 of 988, 7%; P = .002). CONCLUSIONS: In this study, recurrent GNB-BSI was most commonly due to relapse. PFGE accurately differentiated relapse from reinfection when compared with WGS. Cardiac device was a risk factor for relapse.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Bock A, Hanson BM, Ruffin F, et al. Clinical and Molecular Analyses of Recurrent Gram-Negative Bloodstream Infections. Clin Infect Dis. 2023. PMID: 35929656. doi:10.1093/cid/ciac638

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。